Partners HealthCare News
Our researchers receive global recognition
Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, recently shared its list of Highly Cited Researchers™ 2020. This annual list identifies researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade. Their names…
Read MoreMassachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder
Mass General Brigham Innovation Fund Licensing Agreement with Biogen to Focus on Developing Treatment for Inherited Retinal Degeneration Due to Mutations in the PRPF31 Gene July, 2, 2020: (BOSTON) – Massachusetts Eye and Ear, a member hospital of Mass General Brigham, is entering into an exclusive licensing agreement with Biogen to develop a potential treatment…
Read MoreMassachusetts Eye and Ear and Massachusetts General Hospital Advancing Novel Experimental Gene-based COVID-19 Vaccine, AAVCOVID
Massachusetts Eye and Ear and Massachusetts General Hospital (MGH) today announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19. The AAVCOVID vaccine program was developed in the laboratory of Luk H. Vandenberghe, PhD, director of the Grousbeck Gene Therapy…
Read MoreAcquisitions and Successful Financing Add to the Success of the Partners Innovation Fund
The Partners Innovation Fund (PIF) continues to add to their success in moving therapeutic strategies developed within the Partners HealthCare System (PHS) further down the development pipeline. Several recent deals and series A financing rounds support therapeutic strategies for cancer, fibrotic disease, rare endocrine and metabolic diseases and hypothyroidism, among others. Established in 2008, PIF’s…
Read MoreBayer, Brigham and Women’s Hospital, Massachusetts General Hospital open joint lab for research of new treatments for chronic lung
Bayer and Partners HealthCare’s founding members Brigham and Women’s Hospital (BWH) and Massachusetts General Hospital (MGH) today announced the launch of a joint lab to research new drug candidates to treat chronic lung diseases. The joint lab will host scientists from all three parties and Bayer is investing more than USD 30 million to fund…
Read MoreImproving Diagnostic Imaging
If you’ve ever tried to take a picture of a squirming baby, you know how tough it can be to get a quality image of something that’s always on the move. A similar challenge can be found in the more advanced imaging tools used in healthcare diagnostics. To capture high-quality images using MRI or PET…
Read MoreKlibanski Named Modern Healthcare Top 25 Women Leaders
To view the honor and other women leaders in health care, click here.
Read MoreWhen Your Mentor is Named CEO: Reflections
Last week, Anne Klibanski, MD, CEO of Partners Healthcare, was named one of “The Top 25 Women in Healthcare” by Modern Healthcare. Dr. Klibanski, who has been my mentor since I started my endocrine fellowship in 1995, is clearly an exceptional scientist and a visionary leader. As she received this award, I asked myself, how…
Read MoreAnne Klibanski celebrated as CEO and 2019 Top 25 Women Leaders in Health Care by Modern Healthcare
Modern Health Care recently acknowledge the appointment of Anne Klibanski as named first female Partners HealthCare CEO and one of the magazine’s Top 25 Leaders in Healthcare for 2019. We celebrate this recognition and the work of innovative leaders across the healthcare spectrum. Celebrate Accomplishments Women Leaders in Healthcare
Read MorePartners HealthCare names Dr. Anne Klibanski as first-ever female CEO
The Partners HealthCare Board of Directors has named Anne Klibanski, MD President and Chief Executive Officer of Partners HealthCare. Dr. Klibanski becomes the first female chief executive of Partners HealthCare, the state’s largest private employer, with 75,000 employees. Dr. Klibanski was named Interim President and CEO in February. “Over the past several months, it has…
Read MoreHealth Providers Uncover New Revenue Streams to Advance Innovation For Patient Care
The first benchmarking study of health system efforts to generate new revenue streams evaluates a range of effective strategies to sustain overall operations, fuel innovation, and advance patient care missions. The report by Partners HealthCare and Fitzroy Health finds that successful health systems have increased operating margin as much as five points through diversification strategies.…
Read MorePartners HealthCare names Anne Klibanski, MD, as Interim President and CEO; Recognized by Modern Healthcare as one of 2019’s Top 25 Women Leaders
The Partners HealthCare Board of Directors has named Anne Klibanski, MD, Interim President and Chief Executive Officer of Partners HealthCare. Dr. Klibanski will succeed Dr. David Torchiana, who has served since March 2015 and will retire at the end of April. Earlier this month, Dr. Klibanski was recognized by Modern Healthcare as one of 2019’s…
Read MorePartners HealthCare Chief Clinical Officer Featured in PBS’ “Stories From the Stage”
Eureka! Sometimes that moment of personal discovery comes when you least expect it. Heather Berlin came to a revelation while she dangled 40 feet above the Sydney Zoo; Gregg Meyer, MD discovered how tears could make him a better doctor; and Yari Golden-Castaño’s dream of space flight might just take her to Mars. Three storytellers,…
Read MoreAn Innovator’s Feast
Save the Date Westin Copley Place | Boston Wednesday, April 10, 2019 This invitation-only reception honors principal investigators and researchers who submitted invention disclosures during the calendar year 2018. The evening features a cocktail reception, live music from a PHS-member band, dinner and a keynote presentation by Alfred Sandrock, MD, PhD, Chief Medical Officer; EVP,…
Read MoreImproving Hearing and Vision Leadership at Mass. Eye and Ear
Now that the Mass. Eye and Ear has officially joined Partners, leaders from both organizations are optimistic about the potential to drive new advances in treating blindness, deafness and other debilitating diseases of the head and neck. The move comes at a pivotal time as the promise of gene therapies for inherited eye and ear…
Read MoreAI has arrived- Pharma Times
Artificial intelligence is poised to change the pharmaceutical and healthcare industries as it looks to streamline, speed-up and improve overall efficiency. It might still be early days but it’s a bandwagon that organisations are quickly jumping on board. According to a CB Insights report, about 86% of healthcare organisations, life science companies and med tech…
Read MoreAlexion To Acquire Syntimmune
BOSTON–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Syntimmune today announced that they have entered into a definitive agreement for Alexion to acquire Syntimmune, a clinical-stage biotechnology company developing antibody therapeutics targeting the neonatal Fc receptor (FcRn). SYNT001 – a humanized monoclonal antibody that inhibits the interaction of FcRn with Immunoglobulin G (IgG) and IgG immune complexes –…
Read MoreU.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its lead product, Sebacia Microparticles. This significant achievement is a milestone in the treatment of acne and follows the company’s completion of its pivotal study, which clearly demonstrated clinical efficacy…
Read MorePrinted from https://innovationblog.partners.org/our-researchers-receive-global-recognition · Published 03 Dec 2020
© Mass General Brigham Incorporated. All rights reserved.